Skip to main content
Top
Published in: Rheumatology International 5/2011

01-05-2011 | Original Article

Role of sodium silicate in induction of scleroderma-related autoantibodies in brown Norway rats through oral and subcutaneous administration

Author: Sultan M. Al-Mogairen

Published in: Rheumatology International | Issue 5/2011

Login to get access

Abstract

Silica hazard is a growing occupational problem and has been reported to be associated with scleroderma via case reports and occupational studies. The aim of this study is to demonstrate whether oral or subcutaneous silicate exposure can induce an autoimmunity and scleroderma susceptibility in immunosensitive rats. Sodium silicate in a dose of 3 mg in 0.2 ml NS was administered through oral and subcutaneous routes to 20 brown Norway rats. Autoantibodies including ANA, anti-RNP, anti-SCL70 and anti-centromere were measured and compared with pre- and post-challenge serum samples. Serum ANA and anti-RNP were high in significant number of rats (P < 0.05) of only the subcutaneous silicate group. There is an increase in the number of positive readings of autoantibodies at 14th week in comparison with the number of positive readings of autoantibodies at 7th week but P values were not significant. It may be concluded that silicate might induce autoimmunity and scleroderma and it seems to be that the longer the duration of exposure the greater the risk. This is probably the first experimental animal study demonstrating the induction of scleroderma-related autoantibodies after challenge with silicate.
Literature
1.
go back to reference Hess EV (2002) Environmental chemicals and autoimmune disease: cause and effect. Toxicology 181–182:65–70PubMedCrossRef Hess EV (2002) Environmental chemicals and autoimmune disease: cause and effect. Toxicology 181–182:65–70PubMedCrossRef
2.
go back to reference Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60:122–129PubMedCrossRef Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60:122–129PubMedCrossRef
3.
go back to reference Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analysis of the relation between silicone breast implants and the risk of connective-tissue diseases. New Engl J Med 342:781–790PubMedCrossRef Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analysis of the relation between silicone breast implants and the risk of connective-tissue diseases. New Engl J Med 342:781–790PubMedCrossRef
4.
go back to reference McDonald AH, Weir K, Schneider M, Gudenkauf L, Sanger JR (1998) Silicone gel enhances the development of autoimmune disease in New Zealand black mice but fails to induce it in BALB/cAnPt mice. Clin Immunol Immunopathol 87:248–255PubMedCrossRef McDonald AH, Weir K, Schneider M, Gudenkauf L, Sanger JR (1998) Silicone gel enhances the development of autoimmune disease in New Zealand black mice but fails to induce it in BALB/cAnPt mice. Clin Immunol Immunopathol 87:248–255PubMedCrossRef
5.
go back to reference Greenland S, Finkle WD (2000) A retrospective cohort study of implanted medical devices and selected chronic disease in Medicare claims data. Ann Epidemiol 10:205–213PubMedCrossRef Greenland S, Finkle WD (2000) A retrospective cohort study of implanted medical devices and selected chronic disease in Medicare claims data. Ann Epidemiol 10:205–213PubMedCrossRef
6.
go back to reference Bovenzi M, Barbone F, Pisa FE et al (2004) A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77(1):10–16PubMedCrossRef Bovenzi M, Barbone F, Pisa FE et al (2004) A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77(1):10–16PubMedCrossRef
7.
go back to reference Parks CG, Cooper GS (2005) Occupational exposures and risk of systemic lupus erythematosus. Autommmunity 38:497–506CrossRef Parks CG, Cooper GS (2005) Occupational exposures and risk of systemic lupus erythematosus. Autommmunity 38:497–506CrossRef
8.
go back to reference Iannello S, Camuto M, Cantarella S et al (2002) Rheumatoid syndrome associated with lung interstitial disorder in a dental technician exposed to ceramic silica dust. A case report and critical literature review. Clin Rheumatol 21:76–81PubMedCrossRef Iannello S, Camuto M, Cantarella S et al (2002) Rheumatoid syndrome associated with lung interstitial disorder in a dental technician exposed to ceramic silica dust. A case report and critical literature review. Clin Rheumatol 21:76–81PubMedCrossRef
9.
go back to reference Oliver JE, Silman AJ (2006) Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 35:169–174PubMedCrossRef Oliver JE, Silman AJ (2006) Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 35:169–174PubMedCrossRef
10.
go back to reference Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, Pankey H et al (2006) Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum 54:3648–3654PubMedCrossRef Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, Pankey H et al (2006) Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum 54:3648–3654PubMedCrossRef
11.
go back to reference Cooper GS, Parks CG (2004) Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep 6:367–374PubMedCrossRef Cooper GS, Parks CG (2004) Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep 6:367–374PubMedCrossRef
12.
go back to reference Brown JM, Archer AJ, Pfau JC, Holian A (2003) Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol 131:415–421PubMedCrossRef Brown JM, Archer AJ, Pfau JC, Holian A (2003) Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol 131:415–421PubMedCrossRef
13.
go back to reference Al-Mogairen SM, Meo AS, Al-Arfaj SA et al (2009) Induction of autoimmunity in Brown Norway rats by oral and parenteral administration of sodium silicater. Lupus 18:413–417PubMedCrossRef Al-Mogairen SM, Meo AS, Al-Arfaj SA et al (2009) Induction of autoimmunity in Brown Norway rats by oral and parenteral administration of sodium silicater. Lupus 18:413–417PubMedCrossRef
14.
go back to reference Al-Mogairen SM, Al-Arfaj SA, Meo AS et al (2009) Nickel induced allergy and contact dermatitis, dose it induce autoimmunity and cutaneous sclerosis? An experimental study in brown Norway rats. Rheumatol Int J [Epub ahead of print] Al-Mogairen SM, Al-Arfaj SA, Meo AS et al (2009) Nickel induced allergy and contact dermatitis, dose it induce autoimmunity and cutaneous sclerosis? An experimental study in brown Norway rats. Rheumatol Int J [Epub ahead of print]
15.
go back to reference Brown JM, Schwanke CM, Pershouse MA, Pfau JC, Holian A (2005) Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. Am J Physiol Lung Cell Mol Physiol 289(6):L990–L998PubMedCrossRef Brown JM, Schwanke CM, Pershouse MA, Pfau JC, Holian A (2005) Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. Am J Physiol Lung Cell Mol Physiol 289(6):L990–L998PubMedCrossRef
16.
go back to reference Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M et al (2007) Immunological effects of silica and asbestos. Cell Mol Immunol 4:261–268PubMed Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M et al (2007) Immunological effects of silica and asbestos. Cell Mol Immunol 4:261–268PubMed
17.
go back to reference Molokhia M, Mckeigue P (2006) Systemic lupus erythematosus: genes versus environment in high risk populations. Lupus 4:827–832CrossRef Molokhia M, Mckeigue P (2006) Systemic lupus erythematosus: genes versus environment in high risk populations. Lupus 4:827–832CrossRef
18.
go back to reference Cooper GS, Parks CG, Schur PS, Fraser PA (2006) Occupational and environmental associations with antinuclear antibodies in a general population sample. J Toxicol Environ Health A 69:2063–2069PubMedCrossRef Cooper GS, Parks CG, Schur PS, Fraser PA (2006) Occupational and environmental associations with antinuclear antibodies in a general population sample. J Toxicol Environ Health A 69:2063–2069PubMedCrossRef
19.
go back to reference Miller H, Zhang J, Kuolee R, Patel GB, Chen W (2007) Intestinal M cells: the fallible sentinels. World J Gastroenterol 13:1477–1486PubMed Miller H, Zhang J, Kuolee R, Patel GB, Chen W (2007) Intestinal M cells: the fallible sentinels. World J Gastroenterol 13:1477–1486PubMed
Metadata
Title
Role of sodium silicate in induction of scleroderma-related autoantibodies in brown Norway rats through oral and subcutaneous administration
Author
Sultan M. Al-Mogairen
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1327-3

Other articles of this Issue 5/2011

Rheumatology International 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.